| Literature DB >> 32322203 |
Carlos Areche1, Marco Hernandez1, Teresa Cano2, Juana Ticona2, Carmen Cortes3, Mario Simirgiotis3, Fátima Caceres4, Jorge Borquez5, Javier Echeverría6, Beatriz Sepulveda7.
Abstract
Corryocactus brevistylus (K. Schum. ex Vaupel) Britton & Rose (Cactaceae) is a shrubby or often arborescent cactus popularly known as "sancayo" and produce an edible fruit known as "Sanky" which is consumed in Arequipa-Perú. The purpose of this study was to report the gastroprotective activity and relate this activity to the antioxidant capacity and presence of phenolic compounds for the first time. A metabolomic profiling based on Ultrahigh-pressure liquid chromatography and electrospray high resolution mass spectrometry, and the antioxidant activities (DPPH, ABTS, and FRAP), ascorbic acid content, total phenolics and flavonoids contents, and the mode of gastroprotective action of the Sanky fruit including the involvement of prostaglandins, nitric oxide, and sulfhydryl compounds is reported. Thirty-eight compounds were detected in the ethanolic extract including 12 organic acids, nine hydroxycinnamic acids, three isoamericanol derivatives, six flavonoids, five fatty acids, and two sterols. The results of the biological tests showed that the ethanolic extract had antioxidant capacity and gastroprotective activity on the model of HCl/EtOH-induced gastric lesions in mice (at 10, 25, 50, and 100 mg/kg). The effect elicited by the extract at 50 mg/kg was reversed by indometacin and N-ethylmaleimide but not by NG-nitro-L-arginine methyl ester suggesting that sulfhydryl groups and prostaglandins are involved in the mode of gastroprotective action. In conclusion, our study proves that C. brevistylus pears have some gastroprotective and antioxidant capacities and consumption is recommended for the presence of several bioactive compounds.Entities:
Keywords: Cactaceae; Corryocactus brevistylus; flavonoids; gastric ulcer; gastroprotective; phenolics compounds; sancayo
Year: 2020 PMID: 32322203 PMCID: PMC7156589 DOI: 10.3389/fphar.2020.00417
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Corryocactus brevistylus fruits.
Figure 2Ultrahigh-pressure liquid chromatography (UHPLC) chromatogram of (A) total ion current (B) UV at 254 nm and (C) 330 nm of Corryocactus brevistylus edible fruit.
Identification of compounds in Corryocactus brevistylus fruits by UHPLC-PDA-ESI-HRMS/MS.
| Peaks | UV Max | Tentative | [M-H]− | RT (min) | Theoretical | Measured | Accuracy | MSn ions ( |
|---|---|---|---|---|---|---|---|---|
| – | Malic acid | C4H5O5− | 1.46 | 133.0132 | 133.0136 | 2.1 | 115.0030 | |
| – | (iso) citric acid | C6H7O7− | 1.82 | 191.0197 | 191.0190 | 3.7 | 173.0080; 111.0078 | |
| – | Hydroxyglutaric acid | C5H8O5− | 2.10 | 147.0288 | 147.0291 | 2.0 | 129.0184; 111.0078 | |
| – | Hydroxyglutaric acid isomer | C5H8O5− | 2.39 | 147.0288 | 147.0291 | 2.0 | 129.0184; 111.0076 | |
| – | Homo (iso) citric acid | C7H9O7− | 2.86 | 205.0342 | 205.0349 | 3.4 | 187.0245; 161.0451, 111.0078 | |
| 280, 211 | Hydroxybenzoic acid | C7H6O3− | 8.66 | 137.0244 | 137.0237 | 5.1 | 93.1205 | |
| – | Dehydroshikimic acid | C7H11O5− | 8.96 | 175.0612 | 175.0604 | 4.6 | 123.0440 | |
| 211 | Ascorbic acid | C6H7O6− | 9.14 | 175.0248 | 175.0243 | 2.9 | 115.0071; 87.00942 | |
| 213, 287, 326 | Caffeoyl- | C15H17O9− | 9.33 | 341.0873 | 341.0878 | 1.5 | 179.0549; 163.0395 | |
| 217, 288 | Benzoyl aspartic acid derivative | C11H10O5N− | 9.74 | 236.0553 | 236.0561 | 3.4 | 192.0660 | |
| 217, 290, 323 | Benzoyl aspartic acid derivative | C11H10O5N− | 9.88 | 236.0553 | 236.0562 | 3.3 | 192.0660 | |
| 221, 255, 342 | Caffeoyl (iso) citric acid | C15H13O10− | 10.14 | 353.0514 | 353.0513 | 0.3 | 191.0191; 173.0085 | |
| 221, 266, 331 | Caffeoyl (iso) citric acid | C15H13O10− | 10.42 | 353.0514 | 353.0513 | 0.3 | 191.0191; 173.0085 | |
| 221, 268, 318 | Coumaroyl (iso) citric acid | C15H13O9− | 10.68 | 337.0565 | 337.0564 | 0.4 | 163.0394; 154.9977 | |
| 254, 354 | Rutin* | C27H29O16− | 10.93 | 609.1461 | 609.1451 | 1.6 | 301.0345 | |
| 225, 288, 327 | Coumaroyl (iso) citric acid | C15H13O9− | 11.16 | 337.0565 | 337.0563 | 0.6 | 173.0086; 154.9977 | |
| 255, 350 | Isorhamnetin- | C28H31O16− | 11.42 | 623.1617 | 623.1607 | 1.5 | 315.0509, 301.0353 | |
| 228, 290 | Taxifolin | C15H11O7− | 11.67 | 303.0510 | 303.0509 | 0.5 | 163.0394; 125.0235 | |
| 227, 288, 327 | Feruloyl (iso) citric acid | C16H15O10− | 11.90 | 367.0670 | 367.0671 | 0.3 | 193.0506; 179.0344; 163.0395; 111.0079 | |
| 223, 290, 321 | Benzoyl aspartic acid derivative | C13H12O5N− | 12.15 | 262.0553 | 262.0562 | 3.5 | – | |
| 224 | Azelaic acid | C9H15O4− | 12.30 | 187.0964 | 187.0972 | 4.2 | 169.0859; 157.1228, 125.0964 | |
| 225, 312 | Methylcoumaroyl(iso)citric acid | C16H15O9− | 12.72 | 351.0722 | 351.0720 | 0.5 | 173.0084; 163.0394 | |
| 226, 311 | Methylcoumaroyl (iso) citric acid | C16H15O9− | 12.89 | 351.0722 | 351.0719 | 0.4 | 163.0394;119.0494 | |
| 225, 314 | Methylferuloyl (iso) citric acid | C17H17O10− | 13.01 | 381.0827 | 381.0826 | 0.3 | 193.0502; 111.0079 | |
| 223, 283 | Unknown (possibly isoamericanol B1, C1) | C27H25O9− | 13.42 | 493.1493 | 493.1500 | 1.4 | 327.0873, 163.0394 | |
| 223, 285, 328 | Unknown (possibly isoamericanol fragment or derivative) | C18H15O6− | 13.71 | 327.0863 | 327.0874 | 2.3 | 163.0394; 147.0444 | |
| 195, 223, 283 | Unknown (possibly isoamericanol B1 or its isomer C1, B1) | C27H25O9− | 13.42 | 493.1493 | 493.1501 | 1.4 | 327.08736, 163.0394; 133.01353 | |
| 254, 361 | Quercetin* | C15H9O7− | 14.27 | 301.0314 | 301.0315 | 0.3 | 179.0502, 178.9986, 177.0193, 151.0036; 107.0129 | |
| 254, 354 | Isorhamnetin* | C16H11O7− | 15.05 | 315.0510 | 315.0511 | 0.4 | 301.0353, 192.0423, 179.0502, 178.9985, 177.0193, 151.0035; 107.0129 | |
| 251, 351 | Rhamnetin* | C16H11O7− | 18.08 | 315.0510 | 315.0500 | 2.1 | 301.0353, 300.0328, 192.0423, 179.0502, 178.998, 177.0193, 151.0036; 107.0129 | |
| 206 | Trihydroxyoctadecenoic acid | C18H33O5− | 18.49 | 329.2333 | 329.2331 | 0.6 | 393.2282, 349.2384 | |
| 206 | Trihydroxyoctadecenoic acid | C18H33O5− | 19.36 | 329.2333 | 329.2331 | 0.6 | 393.2282, 349.2383 | |
| – | Trihydroxyoctadienoic acid | C18H31O5− | 19.55 | 327.2177 | 327.2178 | 0.5 | 391.2217 | |
| – | Sterol (Peniocerol derivative) | C27H45O7− | 19.65 | 481.3171 | 481.3170 | 0.6 | 463.3165 | |
| – | Hydroxytetraoxodocosanoic acid | C22H35O7− | 22.25 | 411.2389 | 411.2388 | 0.5 | 311.1684 | |
| – | Hydroxytetraoxodocosanoic acid | C22H35O7− | 23.00 | 411.2389 | 411.2388 | 0.6 | 311.1685 | |
| – | Unknown | C30H41O8N3− | 23.52 | 571.2888 | 571.2883 | 0.9 | – | |
| – | Sterol (Peniocerol derivative) | C25H40O7− | 23.98 | 452.2783 | 452.2782 | 0.2 | 463.3168 |
*Compounds identified with spiking experiments with authentic standards
UHPLC-PDA-ESI-HRMS/MS, Ultra-High-Performance Liquid Chromatography-Photodiode Array Detector-Electrospray Ionization-High Resolution Tandem Mass Spectrometry.
DPPH assay, ABTS antioxidant activity (ABTS), ferric reducing antioxidant activity (FRAP), total phenolic content (TPC), total flavonoid content (TFC), and ascorbic acid content (AA) of Corryocactus brevistylus edible fruit extract (n= 5).
| Species | DPPH−a | ABTSb | FRAPb | TPCc | TFCd | AAe |
|---|---|---|---|---|---|---|
| 47.45 ± 0.23 | 225.12 ± 2.42 | 155.34 ± 3.67 | 24.34 ± 3.67 | 13.33 ± 1.88 | 38.46 ± 3.72 | |
| Gallic acid* | 5.47 ± 0.25 | – | – | – | – | – |
| Quercetin* | 7.08 ± 0.65 | – | – | – | – | – |
aAntiradical DPPH and ABTS activities are expressed as IC50 in µg/mL for extracts and compounds; bExpressed as μM TE/g dry weight. cTPC expressed as mg gallic acid/g dry weight; dTotal flavonoid content (TFC) expressed as mg quercetin/g dry weight; eExpressed as mg per 100 g. *Used as standard antioxidants. Values in the same column are significantly different (at p < 0.05).
AA, ascorbic acid content; FRAP, ferric reducing antioxidant power test; TPC, total phenolic content; TFC, total flavonoid content.
Gastroprotective activity of CEX on HCl/EtOH-induced gastric lesions in mice.
| Compound | n | Lesion index | % Lesion reduction | Dose (mg/kg) |
|---|---|---|---|---|
| CEX-10 | 7 | 36.6 ± 4.7* | 18** | 10 |
| CEX-25 | 7 | 29.7 ± 3.3* | 34** | 25 |
| CEX-50 | 7 | 16.7 ± 3.9* | 63 | 50 |
| CEX-100 | 7 | 12.0 ± 3.4* | 73 | 100 |
| Lansoprazole | 7 | 15.7 ± 2.9* | 67 | 30 |
| Control | 7 | 45.3 ± 5.3** | – | – |
The results are expressed as mean ± SD. *P < 0.01 compared with the control and **P < 0.01 compared with lansoprazole (ANOVA followed by Dunnett’s test). n = number of mice.
Effect of crude ethanolic extract (CEX) on the appearance of gastric lesions induced by HCl/EtOH (p.o.) in Indomethacin- (IND), N-ethylmaleimide- (NEM), and N-nitro-L-arginine methyl ester- (L-NAME) pretreated mice.
| Treatment | Dose (mg/kg) | Lesion index (mm) |
|---|---|---|
| Control | – | 41.6 ± 4.9 |
| IND | 10 | 36.0 ± 3.8 |
| NEM | 10 | 38.6 ± 4.4 |
| L-NAME | 70 | 40.7 ± 5.1 |
| 50 | 16.7 ± 3.5* | |
| IND + | 10 + 50 | 35.9 ± 2.8 |
| NEM + | 10 + 50 | 37.7 ± 5.3 |
| L-NAME + | 70 + 50 | 18.0 ± 3.1* |
| Carbenoxolone | 100 | 14.6 ± 4.2* |
Results are expressed as mean ± SD, n = 7. Analysis of variance followed by Dunnett’s test. *P < 0.01 compared with the respective control.
IND, Indomethacin; NEM, N-ethylmaleimide; L-NAME, N-nitro-L-arginine methyl ester.